How To Enroll 612 Patients In A Neurology Study On Time And Within Budget Despite Hurdles Caused By The Pandemic

Dr. Reddy's, a leading Indian pharmaceutical manufacturer, in partnership with OCT Clinical, an Eastern European CRO, launched a Ph3 neurology study. Despite pandemic-driven uncertainty, the enrollment target of 612 patients was reached within an impressive seven months. Through overcoming many challenges in order to figure out a cohesive strategy and solution, the teams, even within the hurdles caused by the COVID-19 nightmare, managed to undertake all activities within the project on time and complete the recruitment of 612 subjects two weeks ahead of the initially agreed schedule.